Effectiveness of Lipomek 2%, a new long-acting antiparasitic ivermectin-based drug, in ruminants affected with siphunculatosis

Abstract

The purpose was to study therapeutic properties of Lipomek 2% drug in animals affected with siphunculatosis, and to determine duration of its action against this pathology. To achieve these goals, 2 species of animals were used. Experiments were conducted at 2 different farms - Mygra and Fazenda, where 25 sheep (Lezgin breed) and 17 calves (Caucasian brown breed) were studied. Animal siphunculatoses are the most common parasitic diseases in Rutul village (Rutul district, Republic of Dagestan). The effectiveness of a new long-acting antiparasitic drug Lipomek 2% (ivermectin) against siphunculatosis in small and bovine animals was studied. A 1% solution of ivermectin also showed a good therapeutic effect which was manifested next week after injection and lasted 21 days. Lipomek 2% (ivermectin) showed 100% efficacy against siphunculatosis in sheep and calves. Duration of parasitocidal effect was maintained for up to 30 days (observation period). No signs of intoxication were observed after livestock treatment.

Keywords

• dagestan
• parasites
• siphunculatosis
• lice
• sheep
• calves
• gelminth
• long-acting drug
• ivermectin
• lipomek